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Homoeopathy for Post COVID 19 illnesses: A Case Series
Abstract
Introduction
Introduction: As much as the prevention and treatment of COVID 19 has posed challenge, its post
infection sequelae have not been any less challenging. There has been an emerging menace and concern
for post COVID 19 illnesses. Patients with microbiological recovery from COVID‐19 show most common
symptoms like fatigue, dyspnoea, cough, headache, tightness of chest, arthralgia, muscle pain with drop
in the quality of life. Limited treatment options are available in the conventional set up. Cases summary
summary:
We present nine cases that were treated for post COVID 19 symptoms at Regional Research Institute (H.),
Mumbai, under Central Council for Research in Homoeopathy. Out of these, seven cases were of acute
Post Covid condition and two presented with Chronic Covid sequelae. All these patients were under
standard conventional care/treatment but had no resolution of Post Covid symptoms. The Post Covid
symptoms reported in these cases were fatigue, dyspnoea on exertion, cough, profuse perspiration, chest
tightness and profuse perspiration. Bryonia Alba was the most useful remedy apart from Sulphur,
Arsenicum Album, Rhus Toxicodendron and Calcarea Carbonicum. The cases have demonstrated a
positive role of homoeopathic treatment in relieving the Post COVID illnesses.
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Abstract
Introduction: As much as the prevention and treatment of COVID-19 has posed challenge, its post-infection sequelae have not been any
less challenging. There has been an emerging menace and concern for post-COVID-19 illnesses. Patients with microbiological recovery from
COVID-19 show most common symptoms such as fatigue, dyspnea, cough, headache, tightness of chest, arthralgia, and muscle pain with
drop in the quality of life. Limited treatment options are available in the conventional setup. Cases Summary: We present nine cases that were
treated for post-COVID-19 symptoms at Regional Research Institute (H.), Mumbai, under Central Council for Research in Homoeopathy. Out
of these, seven cases were of acute post-COVID condition and two presented with chronic COVID sequelae. All these patients were under
standard conventional care/treatment but had no resolution of post-COVID symptoms. The post-COVID symptoms reported in these cases
were fatigue, dyspnea on exertion, cough, profuse perspiration, chest tightness, and profuse perspiration. Bryonia alba was the most useful
remedy apart from Sulphur, Arsenicum Album, Rhus Toxicodendron, and Calcarea Carbonicum. The cases have demonstrated a positive role
of homoeopathic treatment in relieving the post-COVID illnesses.
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Introduction
The humankind has witnessed various viral pandemics tracing
back to the Spanish flu in 1918 down to pandemics of H2N2
in 1957, H3N2 in 1968, SARS-CoV, H1N1 in 2009, MERSCoV, and now the ongoing COVID-19. As challenging the
prevention and treatment of COVID-19, its post-infection
sequelae have been equally challenging. With the total
54,149,731 recovered COVID-19 cases globally and 9,606,111
recovered cases in India till April 2020,[1] the post-COVID
illnesses is an emerging concern.
With the COVID-19 infection triggering several inflammatory
pathways and with the underlying interplay of various
intricate immune mechanisms, a number of cases are reported
from all over the world with post-infection complications
and sequelae from COVID-19. The residual symptoms in
patients with microbiological recovery from COVID-19 show
most common symptoms such as fatigue, dyspnea, cough,
headache, tightness of chest, and muscle pain. An Italian
study followed up 143 persons for 7 weeks post-discharge
and found that 53% reported fatigue, 43% breathlessness,
and 27% joint pain. This study also suggests that among the
patients who had recovered from COVID-19, 87.4% reported
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persistence of at least one symptom particularly fatigue and
dyspnea.[2]
A study done at Leeds Teaching Hospitals, UK, concluded
that in COVID-19 patients fatigue, breathlessness and
psychological distress were reported at 7 weeks after discharge
with a clinically significant drop in the quality of life of many
individuals.[3]
In another study by Yvonne et al. after analyzing, 112
hospitalized patients and 2001 non-hospitalized patients of
COVID-19 fatigue and dyspnea were the most common postCOVID symptoms at follow-up after 3 months from the onset
of the symptoms.[4]
The natural history and pathophysiology of SARS-CoV-2
infection have been a novel area of research. Severity of persistent
symptoms after resolution of acute SARS-CoV-2 infection as
well as risk factors associated with their development is presently
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being studied. The continual sequelae of COVID-19 represent
multiple syndromes resulting from distinct pathophysiological
processes along the spectrum of disease.[5] The most commonly
reported symptoms consist of dyspnea, fatigue, cough,
arthralgia, and chest pain.[3,6,7] Other reported symptoms include
cognitive impairment, depression, myalgia, headache, fever, and
palpitations.[3,6-8] More serious complications appear to be rare but
have been reported, including acute kidney injury,[9] myocardial
inflammation, ventricular dysfunction,[10] etc.
Homoeopathy has shown promising results over many years;
rather centuries, in controlling morbidity as well as mortality
in various epidemics.[11] Homoeopathy is suggested to be
useful in boosting the immunological responses in various
conditions[12] and can thus be used as an adjuvant tool in the
fight against COVID-19 and its sequelae.[13] A number of
medicines are mentioned in the homoeopathic literature[14]
for post-influenza conditions, namely, debility of influenza,
influenza pain remaining, weakness after influenza, etc.,
which cover a wide range of action including weakness,
respiratory, gastrointestinal, rheumatological, cardiac, renal,
and neurological complaints if prescribed on the basis of
symptom similarity.
We present here nine cases treated at the Regional Research
Institute (H.), Mumbai, for post-COVID symptoms.

Case Reports
Case 01

A 62-year-old female was detected to be COVID positive as
per RT PCR report dated October 17, 2020. She was a mild
symptomatic case and was advised home quarantine. On
the 8th day of home quarantine, she developed ulcers in oral
cavity and suffered from muttering delirium with complete
loss of sleep. With an oxygen saturation drop at 90; she was
immediately hospitalized. The hospital stay was 10 days. The
patient was on oxygen therapy with injection remdesivir and
multivitamins for initial 5 days. The patient had a medical
history of diabetes mellitus. The patient experienced lingering
symptoms of fatigue, general weakness, loss of weight, and
bitter taste in mouth for which she visited the institute on
November 21, 2020. She complained of vague body ache after
slightest exertion, especially in evening with perspiration on
slightest exertion associated with palpitations. Considering
the totality [Table 1], Sulphur 30/8 doses twice daily (BD)
were prescribed for 4 days. The patient was followed up on
November 26, 2020, and reported 80% improvement in her
symptoms. The body ache and generalized weakness were
moderately improved. The tiredness was reduced slightly but
was still quite troublesome. Sulphur 200 once daily (OD) for
8 days was prescribed. Next follow-up was taken telephonically
on December 09, 2020, and the patient reported significant
improvement in fatigue, weakness, palpitations, and body ache.

Case 02

A 35-year-old female reported on October 15, 2020, with
complaints of high-grade fever, body ache, headache, dry

cough, and general weakness which were managed by
paracetamol, Vitamin C, and antibiotics for 5 days. She was
subsequently detected COVID positive as per RT-PCR report
on October 17, 2020, for which she was under observation
at a quarantine center. Most of her complaints resolved
within 4–5 days, except dry cough for which nothing had
been effective. Hence, she visited our institute on November
21, 2020 for the complaint. Presenting complaints were dry
cough with itching sensation in throat. Cough bouts lasted for
15–20 min with aggravation usually during eating, talking,
at night and better by drinking warm water. The patient had
increased thirst and Sleeplessness. The patient was anxious
about persistent cough even after 1 month of COVID
diagnosis. Arsenic album 200, 10 doses, twice daily (BD),
were prescribed for 5 days. The patient visited for follow-up
on November 26, 2020, wherein no significant improvement
in cough was observed, rather character of cough changed to
deep hollow cough. With no significant change seen in cough
and need of an instant relief of cough which the patient sought
a change of prescription was done and Bryonia alba 30 thrice
daily (TDS) was prescribed for 7 days. Second follow-up
was taken on telephone on December 09, 2020, wherein the
patient reported moderate improvement in cough. The patient
followed up on December 19, 2020, and reported significant
improvement (90%) in cough bouts and the improvement was
from Bryonia observed on the 4th day of taking it. Bryonia
alba 200 was given subsequently for complete relief of cough
for 4 days.

Case 03

A 37-year-old male was detected COVID positive on
October 19, 2020; and a day before, he had high-grade fever.
He suffered from headache, loss of appetite, and general
weakness which were managed by paracetamol, Vitamin C,
and antibiotic course for 5 days at a quarantine center. His all
complaints resolved within 6–7 days, except for persistent
headaches, fatigue, and mild feverish feeling, especially in
evening, followed by profuse perspiration. The headache was
in frontal and occipital regions, occurring daily for few hours
and was quite troublesome. Hence, the patient visited our
institute on November 21, 2020, with the above complaints.
Considering the symptom totality, Bryonia alba 30 (10
doses) BD was prescribed for 5 days. The patient visited for
follow-up on November 26, 2020, wherein complaints of
headache and feverish feeling reduced significantly. Fatigue
decreased moderately, but was still persistent. Bryonia alba
200 BD was given for 5 days. Telephonic follow-up was done
on December 9, 2020, and the patient reported of significant
improvement in most of his complaints. The patient reported
to the institute on December 19, 2020, informing relief of all
complaints except slight fatigue. The patient had presented
with persistent headaches, fatigue, and mild feverish feeling
followed by profuse perspiration. Out of these, all complaints
decreased significantly with Bryonia except the fatigue.
Hence, to complete the action of remedy, as an anti-miasmatic/
intercurrent remedy, Sulphur 30/2 doses were given OD.
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Table 1: Summary of cases
Case
Date of
Date of
No.
COVID test appearance
of COVID
symptoms

Home isolation/
quarantine
center/
hospitalized

Mild case/
moderate/
severe case

01

17/10/20

25/10/20

Hospitalized

Moderate

35 days

02

17/10/20

15/10/20

Quarantine Centre

Mild

35 days

03

19/10/20

18/10/20

Quarantine center

Mild

37 days

04

22/09/20

17/09/20

Home isolation

Mild

23 days

Home isolation

Mild

05

24/09/20

05/10/20

Duration between Basis of selection of medicines
COVID testing
and initiation of
homoeopathic
treatment

65 days

[Complete] [Generalities]Weakness:
Evening: Agg:
[Complete] [Generalities]Weakness:
Disease: Acute, in or after:
[Complete] [Generalities]Weakness:
Exertion: Agg.: Slight:
[Complete] [Generalities]Weakness:
Perspiration: With:
[Complete] [Generalities]Emaciation:
[Complete] [Generalities]Ill or sick feeling:
[Complete] [Generalities]Weakness:
Extreme:
[Complete] [Generalities]Weariness:
[Complete] [Taste]Bitter:
[Complete] [Perspiration]Palpitation,
during:
[Complete] [Perspiration]Profuse:
[Complete] [Cough]Dry:
[Complete] [Cough]Influenza: After:
[Complete] [Sleep]Sleeplessness:
Restlessness, from:
[Complete] [Sleep]Sleeplessness: Anxiety,
from:
[Complete] [Cough]Itching, from:
[Murphy][Clinical]Convalescence,
ailments, during or since :Pneumonia, after
[Complete] [Head]Pain, headache:
Bursting: Forehead:
[Complete] [Head]Pain, headache:
Forehead:
[Complete] [Generalities]Weariness:
[Complete] [Generalities]Weakness:
Evening: Agg:
[Complete] [Fever, Heat]Evening:
[Complete] [Perspiration]Fever: After:
[Complete] [Chest]Breathing: Difficult,
with:
[Complete] [Generalities]Influenza: After:
[Complete] [Generalities]Pain: Body, all
over:
[Complete] [Perspiration]Profuse:
[Complete] [Respiration]Difficult: Exertion
agg.:
[Complete] [Respiration]Difficult:
[Complete] [Respiration]Difficult: Exertion
agg:
[Complete] [Respiration]Difficult: Expand
lungs, cannot:
[Complete] [Respiration]Difficult: Talking:
Agg:
[Complete] [Respiration]Difficult: Lying:
Agg:
[Complete] [Generalities]Lassitude:
[Complete] [Generalities]Weariness:

Medicine
prescribed

Sulphur

Arsenic
album

Bryonia
alba

Bryonia
alba

Bryonia
alba

(Contd...)
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Table 1: (Continued)
Case
Date of
Date of
No.
COVID test appearance
of COVID
symptoms

Home isolation/
quarantine
center/
hospitalized

Mild case/
moderate/
severe case

Duration between Basis of selection of medicines
COVID testing
and initiation of
homoeopathic
treatment

Medicine
prescribed

06

17/06/20

15/06/20

Home isolation

Mild

112 days

Rhus tox

07

30/09/20

26/09/20

Hospitalization

Mild

33 days

08

02/09/20

09/09/20

Hospitalized

Moderate

28 days

09

15/08/20

11/08/20

Hospitalized

Moderate

115 days

Case 04

A 33-year-old female was suffering from cold, cough, and mild
fever from September 17, 2020, for 2 days, for which 5 days of
azithromycin were taken. She later tested positive for COVID
as per RT PCR report on September 22, 2020, and was home
quarantined for 10 days. During home quarantine, she took
antibiotics along with Vitamin C and paracetamol SOS. The
patient did not have any medical history of any major illness.
On October 5, 2020, the patient started complaining of throat
pain worsening on swallowing, severe body ache, dyspnea on
exertion, and profuse perspiration all over body and on palms

[Complete] [Chest]Pain: Left:
[Complete] [Chest]Pain: Cough: After:
[Complete] [Chest]Constriction:
[Complete] [Chest]Constriction: Anxiety,
with:
[Complete] [Cough]Dry:
[Complete] [Cough]Dry: Evening:
[Complete] [Cough]Dry: Night:
[Complete] [Generalities]Weakness:
Evening: Agg:
[Complete] [Generalities]Weariness:
Exertion: Agg:
[Complete] [Respiration]Difficult:
[Complete] [Respiration]Difficult: Bed, in:
[Complete] [Respiration]Difficult: Eating:
After:
[Complete] [Respiration]Difficult: Expand
lungs, cannot:
[Complete] [Respiration]Difficult: Motion:
Agg.
[Complete] [Respiration]Difficult: Sleep:
Falling asleep, on:
[Complete] [Respiration]Difficult:
Walking: Agg.
[Complete] [Generalities]Weariness:
Exertion: Agg.
[Complete] [Generalities]Lassitude:
Waking, on:
[Murphy] [Clinical]Convalescence,
ailments, during or since :Pneumonia, after
[Complete] [Chest]Pain: Cough: During:
Dry cough :
[Complete] [Respiration]Difficult: Exertion
agg:
[Complete] [Respiration]Difficult: Pain,
during: Chest, in:
[Complete] [Chest]Pain: Inspiration: Agg.
[Complete] [Chest]Pain: Inspiration: Agg.:
Deep:
[Complete] [Generalities]Weariness:
[Murphy] [Chest]Pain, chest: Pneumonia,
after

Bryonia
alba

Bryonia
alba

Bryonia
alba

and soles. The patient was again prescribed with 7 days course
of azithromycin, which failed to resolve her symptoms. She
visited our institute for the same group of lingering symptoms
on October 15, 2020. Considering the totality of presenting
symptoms, Bryonia alba 30 TDS was prescribed for 7 days.
The patient returned for follow-up on October 22, 2020, with
100% improvement in her throat pain, moderate improvement
in other complaints. Slight body ache and dyspnea persisted;
for which Bryonia alba 200 BD was prescribed for 7 days.
On subsequent follow-up on November 3, 2020, the patient
had only complained of profuse perspiration all over body,
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especially on palms and soles. Perspiration was non-offensive
and non-staining. She was asked to take Calcarea Carbonicum
1M three doses at bed time (HS) for three nights. The patient
came for follow-up on December 3, 2020, and reported
significant improvement in not just her symptom of perspiration
on palms and soles, but overall general state of health.

Case 05

A 45-year-old female, though asymptomatic, got RT PCR
test done for travel permission; tested COVID positive on
September 24, 2020. She was advised home quarantine for
14 days. She had slight tiredness and weakness. The patient was
on paracetamol SOS and multivitamin supplement during the
quarantine period, homemade herbal kadha; which she used to
consume occasionally from the past 3–4 months. She had no
medical history of any major illness. On October 5, 2020, she
complained of general weakness, dyspnea on exertion, and back
pain for which she was prescribed analgesics and an antibiotic
course for 7 days, but with no effect. The patient visited our
institute for the same group of symptoms on November 21,
2020; considering the symptom totality, Bryonia alba 30 BD
was prescribed for 5 days. On follow-up on November 26, 2020,
there was 30–40% reduction in severity of dyspnea, backache,
and general weakness, so Bryonia alba 200 BD for 8 days was
prescribed. For dyspnea on exertion, she was already assessed
and treated by Allopathic doctor, moreover, the patient was
relieved in the 1th follow-up itself, so no investigations were
advised. On telephonic follow-up on December 9, 2020, she
said that there was further improvement of 10–20% in all her
complaints. Follow-up on December 15, 2020, revealed that
her general weakness, back pain had reduced significantly,
complaint of dyspnea on exertion had reduced moderately.
Bryonia alba 200 was prescribed twice daily for 5 days to
complete the recovery.

Case 06

A 44-year-old male was tested COVID positive (RT PCR) on
June 17, 2020, after developing fever, body ache, loss of taste,
and smell from June 15, 2020. The patient was home quarantined
for 15 days and was emotionally disturbed as he was all alone at
home and experienced social discrimination from neighborhood.
He was on paracetamol, antibiotic course for 7 days, and
multivitamins; which helped him to recover from his illness
but he had persistent mild left-sided chest pain and slight chest
tightness without any other systemic or vital findings. Hence,
the patient visited our institute for its treatment on October 9,
2020. Considering the symptom totality, Rhus toxicodendron 30
BD was prescribed for 15 days. On follow-up on November 24,
2020, chest pain reduced 50–60%, but the chest tightness was
persistent. Bryonia alba 30 BD was prescribed for 15 days. On
telephonic follow-up on December 9, 2020, the patient reported
of complete improvement in his complaints.

Case 07

A 65-year-old male was detected COVID positive as per RT
PCR test on September 30, 2020. He complained of fatigue and
dry cough since September 26, 2020, and was advised hospital
188

admission for 5 days. He was prescribed antibiotic course of
5 days and multivitamins. There was persistent dry cough with
fatigue thereafter, so the patient visited our institute for the same
complaint on November 3, 2020. The patient had a history of
urticaria on and off for 2 years and fistula in ano. Considering the
acute totality, Bryonia alba 200 TDS was prescribed for 7 days.
The patient reported on November 10, 2020, with significant
relief in dry cough and fatigue. There was urticaria which
reappeared for 2 days. Arsenic album 1M three doses OD were
given with rubrum. Telephonic follow-up was alone on December
10, 2020, which revealed that cough and fatigue complaints were
completely improved and urticaria had also disappeared.

Case 08

A 56-year-old male was detected COVID positive as per RT
PCR test on September 2, 2020. He was home quarantined as
he was asymptomatic, but on September 9, 2020, developed
fever, general weakness, and breathlessness for which he
was hospitalized and managed with intravenous medications,
paracetamol, multivitamins, and antibiotics; along with it, he
was given oxygen therapy for 8 days. The patient was later
discharged from hospital after 12 days of admission, but the
complaint of general weakness, dyspnea on exertion continued,
so on September 30, 2020, the patient visited our institute for
treatment. Considering the symptom totality, Bryonia alba
30 TDS was prescribed for 15 days. On December 9, 2020,
follow-up was taken which reported that dyspnea was relieved
significantly with moderate relief in general weakness. Bryonia
alba 30 BD was given for 7 days. Next follow-up taken on
December 22, 2020, reported significant relief in both dyspnea
and general weakness.

Case 09

A 53-year-old male patient was detected COVID positive,
RT PCR was done on August 15, 2020, as he was suffering
from fever, general weakness, and breathlessness on exertion
from August 11, 2020. He was on antihypertensives, was
hospitalized, and managed with oxygen therapy for 8 days. The
patient was discharged from hospital after 12 days of admission;
but the complaints of general weakness, dyspnea on exertion,
dry cough, and chest pain on deep inspiration continued; so
on December 10, 2020, the patient visited our institute for its
treatment. Considering the symptom totality, Bryonia alba 30
TDS was prescribed for 15 days. On December 15, 2020, the
patient reported marked improvement with 80% decrease in
the complaints of dyspnea and weakness and significant relief
in complaints of chest pain and dry cough; so considering the
remedy reaction, Bryonia alba 30 TDS was continued for
next 7 days. On December 23, 2020, telephonic follow-up was
done and the patient reported significant improvement in all
his complaints, that is, dyspnea on exertion, general weakness,
chest pain, and dry cough.

Discussion
Post-COVID syndrome is a multisystemic disease occurring
after the COVID-19 infection; a better understanding of
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pathophysiology of disease is required for applying various
therapeutic options in post-COVID syndrome. As it involves
several systems of the body, the clinical management requires
“patient as a whole” perspective.[15]
This is one of the few reporting in context to the use of
homoeopathy to manage post-COVID-19 illnesses and
mentions nine cases of post-COVID-19 illnesses that have been
treated with homoeopathic prescription based on presenting

acute totality of the complaints. Medicines were given in
centesimal potencies, and the potency selection and repetition
of doses were done as per the need of the case. Table 1 presents
the patients information with date of RT-PCR done, the onset,
mode of treatment, and the basis of prescription. Table 2 gives
the details of follow-up of patients and the prescription details.
In absence of agreed definition of post-COVID sequelae, the
author has described all there cases on clinical definition,

Table 2: Follow-up of cases
Case No. of
No. followups

Date

01.

21/11/2020 Fatigue, generalized weakness, loss of weight, bitter taste in mouth. Vague body
aches, increased perspiration with palpitations
26/11/2020 80% relief in general weakness, body ache and fatigue
09/12/2020 Significant improvement in fatigue, weakness, and body aches. Palpitations also
decreased
21/11/2020 Paroxysm of dry cough lasting 15–20 min, itching sensation in throat,
sleeplessness, anxiety
26/11/2020 No change in cough; pattern changed to deep hollow cough
09/12/2020 Moderate improvement in cough
19/12/2020 Significant improvement in cough

Baseline
FU 1
FU 2

02.

Baseline
FU 1
FU 2
FU 3

03.

Baseline
FU 1

04.

FU 2
FU 3
Baseline
FU 1

05.

FU 2
FU 3
Baseline
FU 1
FU 2
FU 3

06.

07.

08.

09.

Baseline
FU 1
FU 2
Baseline
FU 1
FU 2
Baseline
FU 1
FU 2
Baseline
FU 1
FU 2

Post-Covid symptoms

21/11/2020 Frontal and occipital headache daily for few hours, fatigue, and mild feverish
feeling, especially in evening followed by profuse perspiration
26/11/2020 Headache and feverish feeling reduced significantly. Fatigue decreased
moderately but still persistent
09/12/2020 Significant improvement in most of his complaints.
19/12/2020 Relief of all complaints except a slight fatigue
15/10/2020 Throat pain worsening on swallowing, severe body ache, dyspnea on exertion,
and profuse perspiration
22/10/2020 Throat pain completely better, moderate improvement in other complaints. Slight
body ache and dyspnea persisted
03/11/2020 All complaints decreased significantly except for profuse perspiration
03/12/2020 Significant improvement in all symptoms including perspiration
21/11/2020 General weakness, dyspnea on exertion, and back pain.
26/11/2020 30–40% improvement in complaints of general weakness, exertional dyspnea, and
back pain
09/12/2020 Further 20% improvement in complaints of general weakness, exertional dyspnea,
and back pain
15/12/2020 General weakness and back pain reduced significantly, dyspnea on exertion
reduced moderately
09/10/2020 Persistent left-sided chest mild pain and slight chest tightness without any other
systemic and vital changes
24/11/2020 50–60% improvement in chest pain, chest tightness persistent
09/12/2020 Complete relief from chest pain and chest tightness
03/11/2020 Persistent dry cough, fatigue
10/11/2020 Dry cough, fatigue better.
Urticaria for 2 days
10/12/2020 Complete relief in complaints of cough and fatigue.
30/09/2020 Dyspnea on exertion, general weakness
09/12/2020 Dyspnea significantly, moderate relief in general weakness.
22/12/2020 Dyspnea significantly, general weakness relieved significantly.
10/12/2020 General weakness, dyspnea on exertion, dry cough, and chest pain on deep inspiration
15/12/2020 Marked (80%) relief in dyspnea on exertion and general weakness. complete
relief in complaints of chest pain and dry cough
23/12/2020 Significant relief in dyspnea on exertion, general weakness, chest pain, and dry cough
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Prescription

Sulphur 30/8 doses BD × 4 days
Sulphur 200 OD × 8 days
No prescription
Arsenic album 200 10 doses BD ×
5 days
Bryonia alba 30 TDS × 7 days
No medication
Bryonia Alba 200
4 doses/once daily
Bryonia alba 30 10 doses BD × 5
days
Bryonia alba 200 BD × 5 days
No medication
Sulphur 30/2 doses/OD
Bryonia alba 30 TDS × 7 days
Bryonia alba 200 BD × 7 days
Calcarea Carb 1M 3 doses/HS
No medicine
Bryonia alba 30 BD × 5 days
Bryonia alba 200 BD × 8 days
No medicine
Bryonia alba 200 BD × 5 days
Rhus Tox 30 BD × 15 days
Bryonia alba 30 BD × 15 days
No medicine
Bryonia alba 200 TDS X 7 days.
Arsenic album 1M 3 doses/ OD
Rubrum BD/15 days
No medicine
Bryonia alba 30 TDS × 15 days
Bryonia alba 30 BD × 7 days
No medicine
Bryonia alba 30 TDS × 15 days
Bryonia alba 30 TDS continued for
next 7 days
No medicine
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published in British Medical Journal by Greenhalgh et al. As
per this definition, the post-COVID sequel is classified into two,
that is, after onset of first COVID-19 symptom if complaints
exist beyond 3 weeks is a post-acute COVID-19 and if same
sequelae goes beyond 12 weeks, it is chronic COVID.[16]
Even though large numbers of papers have been published
in scientific journals and preprint hosting websites, a clear
clinical picture of COVID-19 aftermath is vague. In such
circumstances, homoeopathic therapeutics can be administered
to treat such patients based on the presenting totality of
symptoms. These nine cases have demonstrated a positive
role of homoeopathic treatment in relieving the post-COVID
symptoms.
Every COVID-19 affected individual is not manifesting with the
post-COVID sequelae. Variations exist in individual response
of patients in time to recover from inflammatory and other
immune reactions,[17,18] deconditioning and mental factors such
as post-traumatic stress.[19,20] Here, among the reported nine
cases of post-COVID sequelae, seven cases belong to post-acute
COVID condition and two falls into chronic COVID sequelae.
All these patients were confirmed cases of COVID-19 and under
standard conventional care/treatment but after no resolution of
post-COVID symptoms, the patients reported to the Outpatient
Department of Regional Research Institute (H.), Mumbai. Out
of the nine cases, six cases reported of having fatigue, four
patients presented with dyspnea on exertion, and among them,
three were with cough. Three patients reported with profuse
perspiration which was not previously reported before COVID
infection. Chest tightness was reported in two patients.
All patients were treated on the basis of presenting totality
[Table 1] and the results were promising when evaluated
retrospectively. Patients verbal consent was take for reporting
their cases. The biochemical and radiological evidences of
improvement are essential to make the study more scientific.
These evidences also demonstrate the efficacy of homoeopathy.
However, all the cases presented here, had been treated as
general OPD cases and whatever documents were available
had been recorded as evidence. The positive results of
homoeopathic treatment were observed in a few followsups thus relieving the suffering of patients in shortest time.
However, long-term follow-ups are definitely needed to finally
conclude the efficacy in post-COVID illnesses. Among nine
patients, eight got relief from Bryonia alba and one from
Sulphur. A few medicines such as Arsenicum album, Rhus
toxicodendron, and Calcarea carbonicum were prescribed as
per the necessity [Table 2].
Bryonia alba was also found useful in treating COVID-19 cases
successfully by To et al. at Hong Kong.[21] It was also found
useful remedy in chikungunya.[22] It was also observed that
during Spanish flu pandemic in 1918, Bryonia alba had
acted well.[23] Bryonia alba exhibits strong antiviral and
anti-inflammatory properties due to the pharmaceutical
action of its alkaloids such as 20-dihydrocucurbitacin,
24-dihydrocucurbitacin D (DHCD), and Vitexin.[24,25]
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Conclusion
This case series report depicts that the recovered cases of
COVID-19, which have persistent post-COVID illnesses,
can be successfully treated with homoeopathic medicines.
As spectrum of post-COVID is still to unearth and limited
treatment options are available in the current conventional
scenario for post-COVID sequelae, homoeopathic therapeutics
have promising results to display in shortest time and in an
affordable manner. Bryonia alba seems useful in treating most
of the sequelae of post-COVID illness. Further methodical
research/clinical studies can be taken up to highlight the role
of homoeopathy in post-COVID illness.
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